Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jorge L Poo"'
Autor:
Jonathan S. Chávez-Iñiguez, Jorge L. Poo, Miguel Ibarra-Estrada, Leonel García-Benavides, Guillermo Navarro-Blackaller, Cynthia Cervantes-Sánchez, Eduardo Nungaray-Pacheco, Ramón Medina-González, Juan Armendariz-Borunda, Guillermo García-García
Publikováno v:
International Journal of Nephrology, Vol 2021 (2021)
Background. There is no treatment for septic acute kidney injury (sAKI). The anti-inflammatory activity of prolonged-release pirfenidone (PR-PFD) could be beneficial in this clinical setting. Methods. This study was a double-blind randomized clinical
Externí odkaz:
https://doaj.org/article/b4a04280421240d6ac84bcedb139a0b1
Autor:
Jorge L. Poo, Francisco Sánchez Ávila, David Kershenobich, Xochitl García Samper, Rocío Torres-Ibarra, Julieta Góngora, Carlos Cano, Miguel Parada, Misael Uribe
Publikováno v:
Annals of Hepatology, Vol 7, Iss 4, Pp 369-375 (2008)
Background/Aims: Thymalfasin has shown efficacy in the treatment of chronic HCV infection. The aim of this study was to evaluate the efficacy and tolerability of triple therapy with thymalfasin, peginterferon α-2a (PEG-IFN α-2a), and ribavirin in H
Externí odkaz:
https://doaj.org/article/1dba5215ef104a80acc1c8812c403359
Autor:
Nahum Méndez-Sánchez, PhD, MD, MD Juan R. Aguilar-Ramírez, PhD, MD, Angel Reyes, MD, Margarita Dehesa, MD, Alberto Juárez, MD, Beatriz Castañeda, MD, Francisco Sánchez-Avila, MD, Jorge L. Poo, MD, Luis Guevara González, MD, Javier Lizardi, MD, Miguel A. Valdovinos, MD, Misael Uribe, MD, Ana M. Contreras, MD, Patricia Tirado, MD, Jesús Aguirre, MD, Cesar Rivera-Benítez, MD, Ramón Santiago-Santiago, MD, Francisco Bosques-Padilla, MD, Linda Muñoz, PhD, MD, Arnoldo Guerrero, MD, Mayra Ramos, MD, Heriberto Rodríguez-Hernández, MD, Jannett Jacobo-Karam, MD
Publikováno v:
Annals of Hepatology, Vol 3, Iss 1, Pp 30-33 (2004)
Background: In the last decades it has been suggested that the main cause of liver cirrhosis in Mexico is alcohol. Currently in Western countries hepatitis C virus (HCV) infection is one of the leading causes of endstage liver disease and liver trans
Externí odkaz:
https://doaj.org/article/9c1be387ee89454e8e261b2396b8a6c1
Autor:
Guillermo Garcia-Garcia, Jorge L Poo, Ramón Medina-González, Juan Armendáriz-Borunda, Jonathan S Chávez-Iñiguez, Cynthia Gabriela Cervantes-Sanchez, Miguel Ibarra-Estrada, Guillermo Navarro-Blackaller, Leonel García-Benavides, Eduardo Nungaray-Pacheco
Publikováno v:
International Journal of Nephrology, Vol 2021 (2021)
International Journal of Nephrology
International Journal of Nephrology
Background. There is no treatment for septic acute kidney injury (sAKI). The anti-inflammatory activity of prolonged-release pirfenidone (PR-PFD) could be beneficial in this clinical setting. Methods. This study was a double-blind randomized clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4efd566a191269bb9c7c06755e5919f
https://doaj.org/article/b4a04280421240d6ac84bcedb139a0b1
https://doaj.org/article/b4a04280421240d6ac84bcedb139a0b1
Autor:
Jorge L. Poo, M.D., Linda E. Muñoz
Publikováno v:
Annals of Hepatology, Vol 13, Iss 6, Pp 845-846 (2014)
Externí odkaz:
https://doaj.org/article/a75d0eafb39e4aeca923f21dbf6f45fc
Autor:
Misael, Uribe, Jaime, Morales-Blanhir, Reina, Rosas-Romero, Ricardo, Campos Cerda, Jorge L, Poo
Publikováno v:
Gaceta medica de Mexico. 148(2)
Liver cirrhosis is a complex and progressive disease associated with high mortality. In developing countries, alcoholic liver disease is the most common form of liver cirrhosis, followed by chronic viral disease, especially hepatitis C virus infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3388018eb36a9f130753ef133694725d
https://pubmed.ncbi.nlm.nih.gov/22622315
https://pubmed.ncbi.nlm.nih.gov/22622315
Autor:
Jorge L, Poo, Francisco, Sánchez Avila, David, Kershenobich, Xochitl, García Samper, Rocío, Torress-Ibarra, Julieta, Góngora, Carlos, Cano, Miguel, Parada, Misael, Uribe
Publikováno v:
Annals of hepatology. 7(4)
Thymalfasin has shown efficacy in the treatment of chronic HCV infection. The aim of this study was to evaluate the efficacy and tolerability of triple therapy with thymalfasin, peginterferon alpha-2a (PEG-IFN alpha-2a), and ribavirin in Hispanic pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e1e7b7b1032edcfa16a74f5fddbce27
https://pubmed.ncbi.nlm.nih.gov/19034238
https://pubmed.ncbi.nlm.nih.gov/19034238